Continuous glucose monitoring for pregnant women with gestational diabetes to improve mother and baby outcomes
Official title: The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes: Testing the Moderating Effects of Socioeconomic and Cultural Factors
Run by National Taiwan University Hospital · NCT06436326 · Data updated 2026-11-12
This project will test whether using continuous glucose monitoring helps pregnant women with gestational diabetes and their babies have better health outcomes than usual monitoring.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Hsinchu) |
| Status | Recruiting |
| Started | August 22, 2024 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT06436326 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 or older newly diagnosed with gestational diabetes who do not have preexisting diabetes, can wear sensor adhesives, and are willing to participate are the ideal candidates.
✕Probably not a fit
Women with diabetes diagnosed before pregnancy, those with known skin allergies to adhesives, abnormal coagulation, or who cannot or will not use sensor devices may not receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares continuous glucose monitoring (CGM) with standard blood glucose meters alongside perinatal nursing care for pregnant women diagnosed with gestational diabetes at a Taiwan hospital. Participants will use CGM devices or traditional meters during pregnancy while researchers track glucose patterns, maternal glycemic control, medication needs, and infant outcomes such as birth weight and neonatal complications. The protocol collects data on dietary habits, socioeconomic status, and income to see if these cultural and economic factors change how monitoring method relates to outcomes. Findings aim to show whether CGM provides added benefit in this population and whether effects differ across social or dietary groups.
Why it matters
Potential benefit: If successful, CGM could lead to better blood glucose control during pregnancy and fewer complications for mothers and newborns, potentially with greater benefit in groups with high-carbohydrate diets or differing socioeconomic status.
How similar studies have gone: CGM has shown good control effects in type 1 and type 2 diabetes, but randomized controlled trials in gestational diabetes are limited and have reported inconsistent results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 years or above * Pregnant women diagnosed with gestational diabetes mellitus * Those who are willing to participate in this study Exclusion Criteria: * Those who have been diagnosed with diabetes mellitus "before pregnancy" * Those whose skin is likely allergic to some materials such as tapes (signs and symptoms such as redness, swelling, itching, painful, presenting blisters or rashes caused by wearing breathable tapes, patches, etc.) * Those who is with abnormal coagulation function
Where it's running
-
National Taiwan University Hospital Hsin-Chu Branch BioMedical Park Hospital
Hsinchu, Taiwan Recruiting
Study contacts
- Principal investigator: HUNG-HUI CHEN, PhD — National Taiwan University Hostiptal
- Study coordinator: HUNG-HUI CHEN, PhD
- Email: hunghuichen@ntu.edu.tw
- Phone: 886-2-2394-7109
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Managing cardiometabolic risk in women with gestational diabetes using continuous glucose monitoring and mobile health
This trial will test whether continuous glucose monitoring plus a mobile health lifestyle program helps pregnant women with gestational diabetes control blood sugar and lower cardiometabolic risk for them and their babies.
-
Islet function in gestational diabetes: see if pancreas changes during and after pregnancy
This study tests whether the human pancreas changes its function during and after pregnancy in people with gestational diabetes or not, using Exendin 9-39 in a small Phase 1 trial.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
How dexamethasone affects blood sugar during and after non-cardiac surgery
We will see if a standard dose of dexamethasone raises blood sugar in adults having elective non-cardiac surgery and whether continuous glucose monitors detect changes better than finger-prick tests.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Glucose monitoring in women with polycystic ovary syndrome
This project will use continuous glucose monitors to see if daily glucose patterns differ among adult women with different PCOS phenotypes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.